Camrelizumab/rivoceranibVarious toxicities: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1939卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31534-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：126 / 126

相关论文

共 50 条

[41] Camrelizumab/catequentinibVarious toxicities: case report
Reactions Weekly, 2023, 1951 (1) : 96 - 96
[42] AntineoplasticsVarious toxicities: 4 case reports
Reactions Weekly, 2021, 1866 (1) : 57 - 57
[43] AzathioprineVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1833 (1) : 89 - 89
[44] DeferasiroxMultiple toxicities: 4 case reports
Reactions Weekly, 2022, 1893 (1) : 116 - 116
[45] AdalimumabVarious toxicities: 4 case reports
Reactions Weekly, 2023, 1977 (1) : 17 - 17
[46] AntineoplasticsVarious toxicities: 4 case reports
Reactions Weekly, 2023, 1962 (1) : 54 - 54
[47] CelecoxibVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1697 (1) : 109 - 109
[48] AntineoplasticsVarious toxicities: 4 case reports
Reactions Weekly, 2022, 1937 (1) : 72 - 72
[49] GemcitabineVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1754 (1) : 165 - 165
[50] ImmunosuppressantsVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1795 (1) : 151 - 151

← 1 2 3 4 5 →